Tubiana R - Search Results

1

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease.

Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Li TS, et al. Among authors: tubiana r. Lancet. 1998 Jun 6;351(9117):1682-6. doi: 10.1016/s0140-6736(97)10291-4. Lancet. 1998. PMID: 9734884

2

Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.

Benhamou Y, Katlama C, Lunel F, Coutellier A, Dohin E, Hamm N, Tubiana R, Herson S, Poynard T, Opolon P. Benhamou Y, et al. Among authors: tubiana r. Ann Intern Med. 1996 Nov 1;125(9):705-12. doi: 10.7326/0003-4819-125-9-199611010-00001. Ann Intern Med. 1996. PMID: 8929003

3

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debré P, Leibowitch J. Autran B, et al. Among authors: tubiana r. Science. 1997 Jul 4;277(5322):112-6. doi: 10.1126/science.277.5322.112. Science. 1997. PMID: 9204894 Clinical Trial.

4

[Seropositivity. Antiretrovirus treatments].

Tubiana R. Tubiana R. Soins. 1998 Jan-Feb;(622):19-23. Soins. 1998. PMID: 9574066 French. No abstract available.

5

Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection.

Katlama C, Valantin MA, Matheron S, Coutellier A, Calvez V, Descamps D, Longuet C, Bonmarchand M, Tubiana R, De Sa M, Lancar R, Agut H, Brun-Vezinet F, Costagliola D. Katlama C, et al. Among authors: tubiana r. Ann Intern Med. 1998 Oct 1;129(7):525-31. doi: 10.7326/0003-4819-129-7-199810010-00003. Ann Intern Med. 1998. PMID: 9758571

6

[Immunologic reconstruction after antiretroviral treatment].

Tubiana R, Carcelain G, Mohand HA, Li TS, Renaud M, Blanc C, Calvez V, Debré P, Agut H, Katlama C, Autran B, Bricaire F. Tubiana R, et al. Presse Med. 1999 Feb 27;28(8):424-8. Presse Med. 1999. PMID: 10093603 French.

7

Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen.

Renaud M, Katlama C, Mallet A, Calvez V, Carcelain G, Tubiana R, Jouan M, Caumes E, Agut H, Bricaire F, Debré P, Autran B. Renaud M, et al. Among authors: tubiana r. AIDS. 1999 Apr 16;13(6):669-76. doi: 10.1097/00002030-199904160-00007. AIDS. 1999. PMID: 10397561

8

HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group.

Neumann AU, Tubiana R, Calvez V, Robert C, Li TS, Agut H, Autran B, Katlama C. Neumann AU, et al. Among authors: tubiana r. AIDS. 1999 Apr 16;13(6):677-83. doi: 10.1097/00002030-199904160-00008. AIDS. 1999. PMID: 10397562 Clinical Trial.

9

[Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor].

Mouroux M, Bossi P, Yvon-Groussin A, Delaugerre C, Valantin MA, Tubiana R, Coutellier A, Bonmarchand M, Bricaire F, Katlama C, Agut H, Huraux JM, Calvez V. Mouroux M, et al. Among authors: tubiana r. Pathol Biol (Paris). 1999 May;47(5):549-52. Pathol Biol (Paris). 1999. PMID: 10418038 French.

10

Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy.

Girard PM, Pegram PS, Diquet B, Anderson R, Raffi F, Tubiana R, Sereni D, Boerner D. Girard PM, et al. Among authors: tubiana r. J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):227-35. doi: 10.1097/00126334-200003010-00003. J Acquir Immune Defic Syndr. 2000. PMID: 10839658 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results